SCHEMBL566577

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL566693	0.92	GAA (0.36)	GAASMN1; SMN2MEN1KMT2AALDH1A1
	SCHEMBL566034	0.90	GAA (0.40)	GAASMN1; SMN2MEN1KMT2AALDH1A1
	SCHEMBL566017	0.88	GAA (0.39)	GAASMN1; SMN2MEN1KMT2AALDH1A1
	SCHEMBL566747	0.88	KMT2A (0.36)	GAASMN1; SMN2MEN1KMT2AALDH1A1
	SCHEMBL13258155	0.88	MAPT (0.32)	SMN1; SMN2MAPTPKMKDM4E
	SCHEMBL472295	0.86	CA1 (0.35)	GAAMEN1KMT2A
	SCHEMBL472622	0.86	CA1 (0.33)	GAASMN1; SMN2MEN1KMT2AALDH1A1
	SCHEMBL472769	0.85	CA1 (0.34)	GAAMEN1KMT2A
	SCHEMBL16508607	0.85	CA1 (0.34)	GAA
	SCHEMBL472706	0.84	CA1 (0.32)	—

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.